ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Nerve Regeneration After Nerve Transsection Using (Diffusion-tensor Magnetic Resonance Imaging) DTI MR Imaging

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01020149
Recruitment Status : Completed
First Posted : November 25, 2009
Last Update Posted : March 30, 2016
Sponsor:
Information provided by (Responsible Party):
Gustav Andreisek, University of Zurich

Brief Summary:
To prospectively evaluate the nerve regeneration after traumatic nerve transsection using diffusion tensor magnetic resonance imaging (DTI MR imaging).

Condition or disease Intervention/treatment
Nerve Degeneration Other: MR Imaging

Study Type : Observational
Actual Enrollment : 25 participants
Observational Model: Cohort
Time Perspective: Prospective
Study Start Date : January 2010
Actual Primary Completion Date : January 2016
Actual Study Completion Date : January 2016

Resource links provided by the National Library of Medicine

U.S. FDA Resources


Intervention Details:
    Other: MR Imaging
    MRI is used to evaluate nerve regeneration after traumatic transsection and nerve repair.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
primary care clinic
Criteria

Inclusion criteria:

  • Patients with traumatic nerve transsection and nerve repair.

Exclusion criteria:

  • contraindication for MRI;
  • pregnancy;

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01020149


Locations
Switzerland
Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
Investigators
Study Director: 01 Studienregister MasterAdmins UniversitaetsSpital Zuerich

Responsible Party: Gustav Andreisek, md, University of Zurich
ClinicalTrials.gov Identifier: NCT01020149     History of Changes
Other Study ID Numbers: 003
First Posted: November 25, 2009    Key Record Dates
Last Update Posted: March 30, 2016
Last Verified: March 2016

Keywords provided by Gustav Andreisek, University of Zurich:
Nerve transsection

Additional relevant MeSH terms:
Nerve Degeneration
Pathologic Processes